Showing results (311-320 of 642) with videos related to
Sort By:
Pageof 65
Genes & Nutrition|March 24, 2023
Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activityJoanna L Fiddler, Jamie E Blum, Katarina E Heyden, et al.Neuroimage|July 23, 2011
High b-value and diffusion tensor imaging in a canine model of dysmyelination and brain maturationYu-Chien Wu, Aaron S Field, Ian D Duncan, et al.Archives of Internal Medicine|July 24, 2001
Risk factors for adverse drug events among nursing home residentsT S Field, J H Gurwitz, J Avorn, et al.Clinical Neuroradiology|December 21, 2024
Non-Stenotic Carotid Plaques and Rate of DWI-positive MRI in Patients with Lower-Risk Transient or Persistent Minor Neurologic Events: DOUBT Sub StudyNishita Singh, Fouzi Bala, Francois Moreau, et al.Journal of the American Medical Informatics Association : JAMIA|April 20, 2006
Prescribers' responses to alerts during medication ordering in the long term care settingJames Judge, Terry S Field, Martin DeFlorio, et al.American Journal of Surgery|June 16, 2017
Wide versus narrow margins after partial hepatectomy for hepatocellular carcinoma: Balancing recurrence risk and liver functionWesley B S Field, Jack W Rostas, Prejesh Philps, et al.BMJ (Clinical Research Ed.)|July 27, 2026
Investigation and management of breakthrough ischemic stroke in anticoagulated patients with atrial fibrillationRonda Lun, Umberto Pensato, Joseph R Shaw, et al.Journal of the American Geriatrics Society|December 1, 1994
Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderlyJ H Gurwitz, T S Field, R J Glynn, et al.Diagnostic Cytopathology|February 11, 2011
Assisting cytopathology training in medically under-resourced countries: defining the problems and establishing solutionsA S Field, W Geddie, M Zarka, et al.Dalton Transactions (Cambridge, England : 2003)|December 21, 2006
Synthesis, electrochemistry and luminescence of [Pt{4'-(R)trpy}(CN)](+) (R = Ph, o-CH(3)C(6)H(4), o-ClC(6)H(4) or o-CF(3)C(6)H(4); trpy = 2,2':6',2''-terpyridine): crystal structure of [Pt{4'-(Ph)trpy}(CN)]BF(4) x CH(3)CNJohn S Field, Raymond J Haines, Lesibana P Ledwaba, et al.Pageof 65